28.02.2011
- Novartis said on Monday it would begin a second offer period for shares in U.S. cancer diagnostics company Genoptix after securing acceptances for 80% in the initial offer. The...
31.01.2011
- A bolt-on acquisition in animal health would "make a lot of sense" for diversified Swiss drugmaker Novartis, its chief executive said on Friday. Novartis, which last month wrapped...
25.01.2011
- Swiss drugmaker Novartis is strengthening its personalized medicine and cancer portfolio with the $470 million buy of U.S. cancer diagnostics company Genoptix. The deal, which...
